Skip to main content

Clariant CEO leaves as Sabic deal suspended

6th August 2019

Submitted by:

Andrew Warmington

Clariant and Sabic have agreed to temporarily suspend the discussions on combining the former’s Additives business and the high value part of the Masterbatches business and parts of the latter’s Specialties business into a single ‘High Performance Materials’ business area. The decision was made due to unfavourable market conditions and because they could not agree on the value of the businesses Clariant would bring to the venture, the two companies said. After the announcement, Clariant’s share price fell by 10%.

Saudi petrochemicals giant Sabic acquired a 24.99% stake in Clariant from ‘activist shareholder’ White Tale as part of a move into specialities and the two formulated plans for this combination shortly after. It was White Tale that had prevented Clariant’s attempted merger with Huntsman. In September 2018, the Pigments business was dropped from the venture.

Clariant confirmed that it will continue with the divestment of Pigments and will also divest the entire Masterbatches business by the end of 2020. These make up its Plastics & Coatings business area, which accounts for about half of sales. It plans to use the proceeds to invest in its core businesses, strengthen its balance sheet and return capital to shareholders. Talks will be resumed when conditions are more favourable, Clariant added. However, some analysts have said there is little rationale left in the venture if the Masterbatches business is sold separately.

On the day before, Clariant CEO Ernesto Occhiello had resigned “for personal reasons with immediate effect” after only nine months in the role. To what extent this was linked to the problems with the Sabic deal is unclear. Occhiello was formerly with Sabic and there has been speculation that there was friction between the German-Swiss and Italian parts of the business.

However, former CEO and chairman of the board Hariolf Kottman, who has taken over the reins again until a suitable replacement can be found, denied this, saying that Occhiello’s resignation had been sealed before the decision was taken to call off the joint venture. Kottmann is now heading the executive committee, alongside CFO Patrick Jany and COO Hans Bohnen.

In 1H 2019, sales from continuing operations grew by 4% in local currency terms to CHF 2,229 million, thanks to higher volumes and pricing. EBITDA before exceptional items for continuing operations fell by 2% to CHF 355 million but by 70% when one-off costs of CHF 231 million for an EU investigation into an alleged ethylene purchasing cartel. Kottmann described the half-year as “admittedly challenging”, especially Q2. T

he strongest business areas were Catalysis and Natural Resources, other than Additives, which saw sales decline due to the softer consumer electronics and automotive markets. Masterbatches and Pigments units were 2% down, “negatively impacted by the weakened economic environment”. Care Chemicals had sales of CHF 850 million Swiss francs, with EBITDA before exceptionals of CHF 154 million.

Separately, Clariant has sold its Healthcare Packaging business to a newly-formed affiliate of Arsenal Capital Partners, a private equity firm, for about CHF 308 million. Closing is expected to take place in Q4, subject to customary conditions and approvals. The business had sales of about CHF 135 million in 2018, has facilities in the US, France, China and India, and employs around 600.

UPL to split out specialities

Indian agrochemicals giant UPL has announced plans to transfer its speciality chemicals business, including agrochemical

Submitted by:

Andrew Warmington

AI for SAPs

Together with Algo Artis, Japan’s Nippon Shokubai has developed an algorithm-based means for the production

Submitted by:

Andrew Warmington

Nippon Shokubai's API Facility in Japan

Nucleic acid API boost

Nippon Shokubai is to expand its GMP capacity for nucleic APIs tenfold It will install

Submitted by:

Andrew Warmington

Flamma's facility in Dalian

Flamma opens in China

Italian CDMO Flamma Group has officially opened its new cGMP plant at Dalian, China, where

Submitted by:

Andrew Warmington

GL Chemtec has opened a new kilo lab

GL Chemtec completes kilo lab

CDMO GL Chemtec has announced the completion of a cGMP kilo lab at Oakville, Ontario

Submitted by:

Andrew Warmington

Sterling's facility at Deeside, UK

CDMOs in ADC investments

Five CDMOs across the world have separately announced investments in antibody-drug conjugates (ADCs). Piramal Pharma is

Submitted by:

Andrew Warmington

Afyren Neoxy plant

Milestones for two greentech firms

Afyren has achieved continuous production at its Afyren Neoxy plant at Clermont-Ferrand (pictured)

Submitted by:

Andrew Warmington

Origin by Ocean derives its materials from sargassum

CABB in algae biorefinery deal

CABB has agreed a strategic partnership to establish a first-in-kind algae biorefinery at its site at Kokkola

Submitted by:

Andrew Warmington

First waste-based biosurfactants

Belgian start-up AmphiStar has launched what it claims are the first fully upcycled biobased surfactants

Submitted by:

Andrew Warmington

Aether to supply Seqens

Indian firm Aether Industries has entered into a manufacturing agreement with Chemoxy International, a UK-based

Submitted by:

Andrew Warmington

New model for biocatalysts

BASF, the Austrian Research Centre of Industrial Biotechnology (ACIB) and the University of Graz in

Submitted by:

Andrew Warmington

CBE JU funds 31 more projects

The Circular Bio-based Europe Joint Undertaking (CBE JU), a €2 billion partnership between the EU

Submitted by:

Andrew Warmington

Ribbon cutting ceremony at Lubrizol's new office

Lubrizol opens London office

Lubrizol has opened a new office in Hammersmith, London. This will be home to a

Submitted by:

Andrew Warmington

Sudarshan to buy Heubach

India’s Sudarshan Chemical Industries (SCIL) has entered into a definitive agreement to acquire the Heubach

Submitted by:

Andrew Warmington

Alliance in natural fragrances

Sensegen, a US-based specialist in biotech-enabled fragrances, notably a new class of natural musk raw

Submitted by:

Andrew Warmington

Croda breaks ground in China

Croda International has broken ground for a low-carbon, multi-purpose production facility on a greenfield site

Submitted by:

Andrew Warmington

CCT collaboration for Givaudan

Flavours and fragrances giant Givaudan has agreed a research collaboration for the development of sustainable

Submitted by:

Andrew Warmington

REACH Authorisation

Candidate List ‘reaches’ 250

The European Chemicals Agency (ECHA) has added three more substances to the Candidate List of

Submitted by:

Andrew Warmington

Staff at Brenntag's newly acquired Czech site

CO2-free distribution site first

Brenntag has officially inaugurated what it claims to be the first CO2-emission-free chemical distribution site

Submitted by:

Andrew Warmington